Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
2.580
+0.290 (12.66%)
At close: Feb 5, 2026, 4:00 PM EST
2.599
+0.019 (0.74%)
After-hours: Feb 5, 2026, 7:59 PM EST

Opus Genetics Revenue

Opus Genetics had revenue of $3.08M in the quarter ending September 30, 2025, a decrease of -20.38%. This brings the company's revenue in the last twelve months to $14.63M, up 74.60% year-over-year. In the year 2024, Opus Genetics had annual revenue of $10.99M, down -42.30%.

Revenue (ttm)
$14.63M
Revenue Growth
+74.60%
P/S Ratio
8.76
Revenue / Employee
$812,944
Employees
18
Market Cap
177.93M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.99M-8.06M-42.30%
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 200875.00K--
Dec 31, 200775.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition